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Introduction
Improvements in antenatal management and neonatal intensive care over the past 10 to 15 years have changed the prognosis for preterm infants. More than 85% of infants born at 25 weeks' gestation now survive their preterm birth. This has resulted in a dramatic change in the populations of infants occupying neonatal intensive care beds. The average length of stay for a term or near-term infant who has surgical or respiratory problems is about 15 days; the length of stay for preterm infants born at 26 weeks' gestation is more than 2 months. The duration of hospitalization is inversely related to gestational age.
The population of extremely low-birthweight (ELBW) infants who remain hospitalized for extended periods of time (and who undergo numerous invasive procedures) is most susceptible to nosocomial infections. Nosocomial infections are defined as those that occur beyond 48 hours after birth and are caused by pathogens that are not maternally derived. Such infections are 100 times more common than early-onset bacterial infections, which are caused by pathogens acquired in utero or perinatally. Recent data from the National Institute of Child Health and Human Development-sponsored "Neonatal Network" indicated that 29% of infants born at 25 to 28 weeks' gestation and 46% of infants born at less than 25 weeks' gestation experience a serious nosocomial infection during hospitalization in the NICU.
The morbidity and mortality from nosocomial infections is enormous. In the United States, more than 2,000,000 nosocomial infections (in infants and adults) occur each year, and 50% to 60% are caused by resistant organisms. It has been estimated that 9,600 to 20,000 patients die each year in the United States from catheter-related bloodstream infections. Nosocomial infections increase the costs of neonatal intensive care, prolong hospitalization by several weeks, and are responsible for almost 50% of the deaths that occur beyond 2 weeks of age. Although the epidemiology of neonatal nosocomial infections is complex, both simple and theoretical strategies can reduce the frequency of hospitalacquired infections. This article discusses the epidemiology and prevention of nosocomial infections in the neonatal intensive care unit (NICU).
Epidemiology and Microbiology
Over the past 50 years, the epidemiology of pathogens responsible for nosocomial infections in neonates has changed dramatically. During the 1950s, Staphylococcus aureus phage type 80/81 was the most common nosocomial pathogen in hospitalized infants. During the 1960s, gram-negative bacilli, including Pseudomonas aeruginosa, Klebsiella sp, and Escherichia coli, became the most common pathogens. By the 1970s, coagulasenegative staphylococci (CONS) (predominantly S epidermidis) and S aureus, including methicillinresistant S aureus (MRSA), became the predominant causes of hospitalacquired infections in the NICU. Today, gram-positive cocci continue to cause the largest proportion of infections, and many, including MRSA, CONS, and vancomycin-resistant enterococci (VRE), are multidrug-resistant. Gram-negative bacilli are responsible for 20% to 30% of cases of lateonset sepsis and 30% of nosocomial pneumonias (Table 1) . Many gramnegative pathogens are also multidrug-resistant, including organisms that express extendedspectrum beta-lactamases such as K pneumoniae, K oxytoca, and other enterobacteriaceae such as E coli. Such enzymes can degrade thirdgeneration cephalosporins, and organisms expressing these beta-lactamases may be treated successfully only with carbapenem antibiotics such as imipenem and meropenem. Candida sp, particularly C albicans and C parapsilosis, have become increasingly common and cause about 10% of late-onset infections. Finally, viral pathogens also can cause infections in NICU patients, and outbreaks of respiratory syncytial virus (RSV) and rotavirus infections (in parallel with community outbreaks) have been well described. Because every unit has its own, unique endemic flora, active surveillance for nosocomial infections is critical to guide empiric antibiotic therapy and implement effective preventive strategies.
Bacterial Pathogens

Coagulase-negative Staphylococci
Since the late 1970s and early 1980s, CONS, particularly S epidermidis, have been recognized as the most common cause of hospital-acquired infections in infants in the NICU. The burden of infections from these microorganisms in affected infants is enormous. Approximately 40% of all infections are caused by CONS, and nearly 5% of NICU patients develop bacteremia with CONS. Overall, these pathogens are responsible for 40% to 50% of bloodstream infections; 29% of eye, ear, nose, and throat infections; 19% of skin and soft-tissue infections; 16% of pneumonias; and 10% of infections of the gastrointestinal tract. The precise incidence of CONS infections is difficult to determine because it often is difficult to distinguish a true infection with CONS from "culture contamination" if only one blood culture is obtained.
CONS also can cause meningitis, ventriculoperitoneal shunt infections, and right-sided endocarditis associated with the use of central venous catheters or umbilical venous catheters. Infections due to CONS are late-onset infections; bloodstream infections occur most commonly during the third week of hospitalization. Fortunately, CONS infections generally are more indolent than infec- 
Staphylococcus aureus
S aureus is a common pathogen in the NICU and may be virulent. S aureus causes bloodstream infections and sepsis, skin/soft-tissue/wound infections, osteoarthritis (which can be multifocal), and less commonly, central nervous system infections such as meningitis and ventriculitis. Similarly to CONS, the pathogenesis of S aureus is related to patterns of colonization. It can colonize the skin, nares, nasopharynx, gastrointestinal tract, respiratory tract, or eyes.
Approximately 7% to 9% of cases of late-onset sepsis, 17% of pneumonias, and 22% of surgical site infections in patients in the NICU are caused by S aureus. Risk factors for methicillin-susceptible S aureus (MSSA) infection/ colonization include prolonged duration of hospitalization and low birthweight.
Most MRSA infections appear to be associated with outbreaks. Healthcare workers frequently are implicated in transmission; MRSA colonize the anterior nares and spread from patient to patient by transient hand carriage. MRSA can become endemic and may colonize as many as 36% of infants in an NICU. Risk factors for MRSA acquisition are increased length of hospitalization, antibiotic exposure, and instrumentation (eg, indwelling catheters). MRSA does not appear to be more virulent than MSSA, but healthcare costs associated with MRSA are generally higher.
Enterococci
Enterococci are an occasional cause of infections in the NICU. Overall, 6% of late-onset sepsis cases, 5% of pneumonias, and 9% of surgical site infections are caused by enterococcal species. The Pediatric Prevention Network point-prevalence survey from 1999 reported that 10.3% of bloodstream infections and 16.7% of urinary tract infections were attributed to enterococci. Risk factors for colonization of the gastrointestinal tract and subsequent infection include increased length of hospitalization, use of indwelling catheters, and prolonged use of antibiotics.
Outbreaks of vancomycin-resistant E faecium (VREF) have been described. Extensive environmental contamination has been noted, and outbreaks have been terminated successfully by improved cleaning, restricted use of vancomycin, cohorting of infected/colonized infants, and the use of contact precautions. Among the risk factors for VREF are prolonged treatment with antimicrobial agents and low birthweight.
Gram-negative Pathogens
PSEUDOMONAS AERUGINOSA P aeruginosa is a well known cause of sepsis, pneumonia, conjunctivitis, and endophthalmitis and is associated with high mortality rates. Potential reservoirs for P aeruginosa in the NICU include resuscitation equipment, humidifiers, incubators, formulas, breast pumps, sinks and sink drains, tap water, infants who have prolonged lengths of stay, and the hands of healthcare workers. Among the risk factors for P aeruginosa infection are feeding intolerance, prolonged need for parenteral hyperalimentation, and prolonged treatment with antibiotics.
KLEBSIELLA SP Klebsiella sp, particularly K pneumoniae and K oxytoca, are well-established pathogens in NICU patients that cause sepsis, urinary tract infections, and pneumonia. During the 1970s, the most common cause of outbreaks in the NICU was Klebsiella sp, and most were kanamycin-resistant. More recently, extended-spectrum beta-lactamase-producing (ESBL) Klebsiella sp have been identified that are resistant to third-generation cephalosporins. The plasmid containing the ESBL gene can be transmitted to other Enterobacteriaceae sp in vivo.
ENTEROBACTER SP
Enterobacter sp, such as E cloacae, E agglomerans, and E sakazakii, are less common causes of hospital-acquired infections in NICUs. Enterobacter sp are multidruginfectious diseases nosocomial infections resistant pathogens and can cause sepsis and meningitis in preterm infants. Infections with these pathogens are associated with high mortality rates. Several outbreaks have been linked to intrinsically contaminated dextrose for intravenous infusion and powdered infant formula.
Fungal Pathogens
CANDIDA SP For more than 2 decades it has been recognized that preterm infants are at increased risk for infections caused by Candida sp, particularly C albicans and C parapsilosis. Other Candida sp, such as C tropicalis, C lusitaniae, and C glabrata, are less common causes of late-onset sepsis. Resistance to fluconazole and amphotericin can occur in Candida sp, and testing for susceptibility should be considered if there is a poor clinical response. Candida sp cause candidemia, particularly catheter-related, bloodstream infection, and less commonly, urinary tract infections, endocarditis, osteomyelitis, and meningitis. The crude mortality rate after infection with Candida sp ranges from 23% to 50%.
Risk factors for invasive disease caused by fungal pathogens include prematurity, central venous catheters, histamine 2 blockers, antibiotics, parenteral nutrition, intravenous lipids, intubation, prolonged length of hospitalization, and colonization with Candida sp, particularly in the respiratory or gastrointestinal tracts. (See also Kicklighter SD. Antifungal agents and fungal prophylaxis in the neonate. NeoReviews. 2002; 3:e249-e255.) MALASSEZIA SP AND TRICHOSPORON SP Malassezia sp, particularly M furfur and M pachydermatis, are well described, less common causes of late-onset infections. The most important risk factor is the use of intravenous lipids because M furfur has the critical growth requirement of exogenous fatty acids C 12 to C 24 . Malassezia sp fungemia generally resolves with central catheter removal; patients do not appear to require systemic antifungal agents.
Viruses
Hospital-acquired viral infections in NICU patients parallel community illnesses. As many as 30% of infections of the gastrointestinal tract and 5% of eye, ear, nose, and throat infections are caused by viral illnesses. Outbreaks caused by respiratory viruses such as RSV and influenza have been described, as have outbreaks caused by rotavirus. Preterm infants may be asymptomatic and may shed viruses for prolonged periods, thus contaminating the environment and facilitating patient-to-patient spread via the hands of staff. Ill healthcare workers also may be the source of nosocomial viral infections. Detection of viral pathogens requires a high index of suspicion because symptoms of viral illnesses in preterm infants may be nonspecific (eg, apnea, temperature instability). Appropriate diagnostic studies must be ordered.
Bloodstream and Catheter-related Bloodstream Infections
Bloodstream infections represent the most common nosocomial infection of patients in the NICU, and many such infections are catheter-related. ELBW infants exhibit the highest rate of these infections, but bloodstream infections remain the most common infection, even among infants whose birthweights are 2,500 g or greater. Late-onset sepsis is an important determinant of morbidity and mortality; the length of hospitalization increases in infants treated for sepsis. The overall risk of dying of late-onset sepsis is 17%; rates are higher for gram-negative pathogens such as P aeruginosa (40%) and fungi (15% to 50%) and lower for CONS (10%). As even smaller preterm infants survive, the mortality rate due to respiratory causes among infants whose gestational age is 23 to 27 weeks has decreased, but the mortality rate from sepsis increased from 14% in 1983 through 1990 to 44% in 1992 through 1996.
Respiratory Tract Infections
Pneumonia is the second most common nosocomial infection in patients in the NICU and causes about 15% of hospital-acquired infections. The rate of ventilatorassociated pneumonia varies by center, with a median of 3.3 episodes of pneumonia per 1,000 ventilator-days. Although both gram-negative and -positive pathogens cause pneumonia, mortality from the former is much higher. Accurate diagnosis of nosocomial pneumonia can be very difficult in preterm infants because radiographic changes may be due to atelectasis or noninfectious diseases such as bronchopulmonary dysplasia rather than infection, and infants rarely undergo invasive diagnostic procedures such as bronchoscopy.
Strategies for Prevention of Nosocomial Sepsis
Reducing the incidence of nosocomial sepsis requires a multifaceted approach. Prevention of preterm birth is potentially the most effective strategy to decrease the risk of nosocomial sepsis by reducing the size of the most susceptible population in the NICU. A review of that topic is beyond the scope of this paper (see Guinn D, Gibbs R. Infection-related preterm birth: a review of the evidence. NeoReviews. 2002;3:e86-e96), but it is worth infectious diseases nosocomial infections noting that the rate of prematurity has significantly increased in the United States over the past 20 years.
There are, however, a number of simple care practices that can reduce the probability of an infant developing a hospital-acquired infection. These include elimination of overcrowding and understaffing, careful preparation and storage of infant formulas, decreasing the number of heel sticks and attempts at venipuncture, using single-dose administration of medications such as albumin, avoiding drugs associated with an increased risk of nosocomial infection (histamine 2 blockers and dexamethasone), sterilization of resuscitation bags and masks, and use of sterile suctioning techniques. Because many episodes of bacteremia are associated with indwelling lines or mechanical ventilation, common sense dictates avoiding their use or minimizing the number of catheter or ventilator days. Ventilator days can be minimized by using interventions that prevent or lessen the severity of respiratory distress syndrome (eg, antenatal steroids and surfactant), permit rapid weaning (eg, permissive hypercapnia, closure of a patent ductus arteriosus), or use noninvasive forms of respiratory support such as continuous positive airway pressure.
Care practices that are likely to reduce the incidence of catheter-related infections include: early institution of enteral feedings, use of human milk feedings, discontinuation of parenteral alimentation (especially intravenous lipids) a few days short of full feedings, impeccable central venous catheter care (sterile insertion techniques by skilled personnel and dressing changes with careful disinfection of the insertion site and care of the hub), limitation of open catheter circuits and heparin flushes, careful preparation of intravenous fluids and blood products, and routine change of administration sets every 72 hours (or within 24 hours if lipids are used). Recently suggested novel preventive technologies that have been examined in adults include use of silver sulfadiazineimpregnated catheters and cuffs, heparin-bonded catheters, and antibiotic-coated (eg, rifampin-minocycline) and -impregnated catheters. The latest Healthcare Infection Control Practices Advisory Committee (HICPAC) guidelines (2002) recommend use of chlorhexidine for cutaneous antisepsis and anti-infective-impregnated catheters if institutional rates of infection are greater than 3.3 bloodstream infections per 1,000 catheter days despite full adherence to maximal barrier precautions, especially for high-risk patients. Those guidelines have not been adapted for the neonatal population. Furthermore, antiseptic-or antibiotic-impregnated catheters are unavailable for the NICU population.
Handwashing/"Degerming"
Handwashing and "degerming" remain the simplest and most effective methods of preventing transmission of infectious agents from clinicians to infants and infants to infants. Six of seven hospital-based studies (including two in NICUs) demonstrated that improved hand hygiene techniques significantly reduced infection rates. The fourth edition of the Guidelines for Perinatal Care recommends the following practices:
• Personnel should remove rings, watches, and bracelets before entering nursery or obstetric areas.
• Fingernails should be trimmed short, and no artificial fingernails or nail polish should be permitted.
• A 10-second wash is recommended before and after handling each infant.
Three types of skin flora colonize the hands of nursery personnel: resident flora survive and multiply on the skin, transient flora represent recently acquired "superficial" contamination and may include pathogens acquired from one patient and potentially transferable to another, and infectious flora (eg, S aureus) are capable of causing localized infections in healthcare workers or infants. Handwashing with soap and water is the most effective method of removing soil or proteinaceous material and also may decrease the number of transient flora (because they reside on the skin surface). However, handwashing with soap and water also carries the risk of dispersing bacterial colonies. Even brief skin-to-skin contact can transmit several logs of bacteria. Degerming (using an alcohol-based hand rub with emollient) currently is recommended before and after all patient contacts. It is effective at reducing the number of bacterial, fungal, and viral pathogens.
A number of alcohol-containing products are available, but recent data suggest variations in effectiveness. Skin emollients decrease the dispersal of bacteria, but may reduce the effectiveness of chlorhexidine-containing soaps. Soaps and detergents (particularly those that are anionic and cationic), paper towels, and gloves can damage the skin, and damaged skin harbors more potential pathogens. In addition, frequent handwashing (even with soap and water) may affect skin health adversely by raising the pH. Routine gowning in the nursery has not been shown to be an effective strategy, but should be used by healthcare workers coming in contact with infants who are colonized with pathogenic or resistant microorganisms to avoid contaminating the clothing of healthcare workers. Gloves have been advocated as a method of reducing infections, but they may worsen skin condition and promote bacterial growth. Gloves should infectious diseases nosocomial infections be worn when caring for infants on droplet or contact precautions or when touching blood, body fluids, respiratory tract secretions, mucous membranes, or objects (including equipment) contaminated by these secretions.
Needless to say, compliance with handwashing is poor. In a recent interventional study to evaluate the impact of an alcohol-based gel in improving hand hygiene compliance, Harbarth and associates demonstrated that the use of an alcohol-based gel improved compliance, but even with an active educational program, compliance never exceeded 50%. Doctors and nurses remain the least compliant groups.
The skin of preterm newborns is thinner, more permeable, and more easily injured with minor trauma compared with term infants. This has led some investigators to recommend application of topical emollients to the smallest infants. Two small, randomized trials suggested that topical emollient therapy might reduce the incidence of bloodstream infections, but the risk of nosocomial infection was not decreased in a recently completed large, randomized clinical trial of infants weighing 500 to 750 g.
Skin Antisepsis
Skin antisepsis at catheter insertion sites and sites of venipuncture is essential. Eight randomized, prospective trials compared 10% povidine-iodine with chlorhexidinecontaining antiseptic for prevention of bloodstream infections involving central venous catheters and arterial catheters. Seven of the trials found lower rates of catheter colonization in the chlorhexidine group, and three of five trials showed a significant reduction in central venous catheter-related bloodstream infections. Only a single study (comparing 0.5% chlorhexidine with povidoneiodine) was conducted in a NICU, but the study was not sufficiently large to assess differences in bloodstream infection rates. In a recently published randomized trial in neonates, the use of a chlorhexidine patch reduced catheter tip colonization, but not bloodstream infections. Infants assigned to the chlorhexidine patch group had an increased risk of contact dermatitis. At present, skin antisepsis is not recommended for neonates (Infectious Diseases Society of America, HICPAC guidelines).
Antibiotic Prophylaxis
As noted previously, CONS (most frequently S epidermidis) are the most common pathogens responsible for nosocomial sepsis in neonates. Two smaller randomized trials documented a reduction in the number of bloodstream infections when vancomycin (25 mcg/mL) was added to intravenous solutions. No vancomycin-resistant bacteria were detected in surveillance cultures, but concern about the development of vancomycin resistance remains. This is particularly true in an era when VRE are increasingly prevalent. Furthermore, vancomycin resistance recently has been detected in strains of S aureus. There also has been interest in the use of antifungal agents to prevent infections with Candida sp. The use of topical nystatin has not reduced the incidence of fungal infections. In a recently published randomized clinical trial, the use of prophylactic fluconazole resulted in a reduction in colonization and invasive fungal infections. Although fluconazole resistance was not detected in this study, resistance to this agent is well described among several Candida sp. A multicenter study is being planned.
Immunoprophylaxis
Reduced transplacental transfer of immunoglobulins and decreased endogenous synthesis of immunoglobulin G predispose preterm infants to nosocomial infections. This physiologic hypogammaglobulinemia provides a rationale for prophylactic administration of intravenous immune globulin (IVIG). Ohlsson and Lacy from the Cochrane Neonatal Group recently reported a metaanalysis of 19 randomized trials of prophylactic immune globulin in very low-birthweight infants. When all studies were combined, there was a significant (3%) reduction in the incidence of sepsis, but there was no reduction in mortality. Therefore, the use of IVIG is of marginal importance and because of cost considerations should not be used.
The recombinant forms of some hematopoietic cytokines have been cloned and purified and have been under clinical investigation for their possible role in modulating the host defense system to prevent neonatal sepsis. Granulocyte colony-stimulating factor (G-CSF) and granulocyte-macrophage colony-stimulating factor (GM-CSF) have the ability to increase the number of circulating neutrophils and to augment the "cidal" activity of neutrophils and macrophages against infectious organisms. Data for the efficacy of G-CSF are limited. A small study (nϭ28) demonstrated reduced infection incidence in babies who had neutropenia born to women who had pregnancy-induced hypertension. In a large randomized clinical trial using GM-CSF (nϭ264), Cairo did not achieve a significant reduction in the incidence of nosocomial sepsis. However, in a smaller study by Carr (nϭ75), the incidence of bloodstream infection was reduced from 46% to 31% with prophylactic GM-CSF. 
Quality Improvement
As noted previously, changing a number of simple care practices can reduce the risk of nosocomial sepsis. Horbar and collaborators in the Vermont Oxford Study Group initiated a multidisciplinary collaborative quality improvement project to reduce the incidence of nosocomial infections in six intensive care nurseries. Interventions fell into six categories ( 
Nutrition
• No alteration of hyperalimentation solutions after preparation.
• Initiation of enteral feedings as early as possible.
• Reduced exposure to intravenous lipids and hyperalimentation.
• Promotion of the use of human milk, ensuring proper collection and storage.
Skin Care
• Initiation of a skin care protocol for all neonates weighing <1,000 g, the goals of which are to promote skin maturation and to prevent skin breakdown.
• Reduced laboratory testing that requires venipuncture or heelstick.
• Development of a systematic approach to intravenous therapy that reduces the frequency and number of skin punctures for placement of an intravenous catheter.
Diagnosis
• Establishment of a minimum sample size for a blood culture that is 1 mL per aerobic culture bottle.
• Preference for two samples of 1 mL each in two aerobic culture bottles.
• Development of a method to distinguish true infection from a contaminated culture.
Respiratory Care
• Minimization of intubation days.
• Minimization of the interruption of the ventilator-endotracheal tube circuit.
Vascular Access
• Minimization of the use of central lines, and when used, minimization of the frequency of daily entries and the duration of use.
• Prospective placement of central lines when intravenous therapy will be of long duration.
• Establishment of sound policies and procedures for line care and access and regular monitoring of compliance.
Unit Culture
• Promotion of developmentally supportive care, with an emphasis on minimal handling.
• Development and maintenance of a culture of cooperation and teamwork that supports and encourages all team members to feel responsible for outcomes.
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